Journal of Virology · 2008 · 78 citations · 48 references
ImmunologyViral PathogenesisPathologyImmunotherapyCancer-associated VirusType 1Epstein-barr VirusVirus GeneViral GeneticsLymphoid NeoplasiaType 2VirologyGene ExpressionCell BiologyTumor MicroenvironmentPathogenesisAdult T-cell Leukemia-lymphomaMedicineDifferential Gene Regulation
A transfection assay with a lymphoblastoid cell line infected with Epstein-Barr virus was used to compare the abilities of type 1 and type 2 EBNA2 to sustain cell proliferation. The reduced proliferation in cells expressing type 2 EBNA2 correlated with loss of expression of some cell genes that are known to be targets of type 1 EBNA2. Microarray analysis of EBNA2 target genes identified a small number of genes that are more strongly induced by type 1 than by type 2 EBNA2, and one of these genes (CXCR7) was shown to be required for proliferation of lymphoblastoid cell lines. The Epstein-Barr virus LMP1 gene was also more strongly induced by type 1 EBNA2 than by type 2, but this effect was transient. Type 1 and type 2 EBNA2 were equally effective at arresting cell proliferation of Burkitt's lymphoma cell lines lacking Epstein-Barr virus and were also shown to cause apoptosis in these cells. The results indicate that differential gene regulation by Epstein-Barr virus type 1 and type 2 EBNA2 may be the basis for the much weaker B-cell transformation activity of type 2 Epstein-Barr virus strains compared to type 1 strains.
48
DNA sequence and expression of the B95-8 Epstein—Barr virus genome
Richard Baer, Alan T. Bankier, Mark D. Biggin et al. · Nature · 1984 · 2K citations
Epstein-Barr virus and its replication
Elliott Kieff · Medical Entomology and Zoology · 1996 · 1.6K citations
Martin Rowe, David Rowe, Christopher D. Gregory et al. · The EMBO Journal · 1987 · 723 citations · Full text
Lymphoid Neoplasia, Lymphocyte Development, Lymphoma Cells +6